Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493018 | SCV000582428 | likely pathogenic | not provided | 2017-08-21 | criteria provided, single submitter | clinical testing | The R2185W variant in the SZT2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R2185W variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R2185W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. The R2185W variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded |
Invitae | RCV000493018 | SCV001567213 | likely pathogenic | not provided | 2023-05-08 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SZT2 protein function. ClinVar contains an entry for this variant (Variation ID: 429775). This missense change has been observed in individuals with SZT2-related conditions (PMID: 30560016, 30818181). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs765848129, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 2185 of the SZT2 protein (p.Arg2185Trp). |
Institute for Biomedicine, |
RCV000664408 | SCV000786628 | likely pathogenic | Developmental and epileptic encephalopathy, 18 | 2018-07-16 | no assertion criteria provided | research | This variant and NM_015284.3:c.498G>T (also submitted to ClinVar) were observed in a compound-heterozygous state in two affected brothers. The mother was unaffected and carried NM_015284.3:c.498G>T but not this variant, the father and another brother were unaffected and carried this variant but not NM_015284.3:c.498G>T. |
OMIM | RCV000664408 | SCV001481163 | pathogenic | Developmental and epileptic encephalopathy, 18 | 2021-02-19 | no assertion criteria provided | literature only |